Brind.

Editas Medicine is developing oncology products in collaboration with Bristol Myers Squibb.

1 report, 1 independent Updated Aug 12

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Editas Medicine Bristol-Myers Squibb

Keep exploring

The entities involved

Editas Medicine
discovery-phase pharmaceutical company

Nothing else this week.
Bristol-Myers Squibb
American pharmaceutical company
- Bristol-Myers Squibb is developing innovative treatments and supporting Cyprus' national effort in haematology.Mon 13:45
- FDA gave tentative approval to Lupin for an alternative formulation of a Bristol-Myers Squibb drug, which Lupin plans to manufacture in Somerset.Mon 09:09

Related events

Coverage

Newest first; wire copies grouped

Aug 12Motley FoolCan This Beaten-Down Stock Bounce Back? Editas Medicine's shares are up in 2025, but the stock has lagged the market in recent years. The struggling biotech decided to shift its strategy after encoun